Harvard Bioscience Inc HBIO
$7.48 $0.07 (0.93%) 1D
Last Updated: Aug 21, 08:00 PM·NASDAQ
Pricing for US stocks is delayed by 24 hours
HBIO Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Harvard Bioscience Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Harvard Bioscience Inc. Stock Analysis HBIO
United States Health Care Nano Cap Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 316 full-time employees. The company went IPO on 2013-10-21. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Harvard Bioscience Inc (HBIO) Chart
Financial Metrics & Statements of Harvard Bioscience Inc (HBIO)
FAQ's for Harvard Bioscience Inc (HBIO)
- As of August 2026, Harvard Bioscience Inc HBIO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Harvard Bioscience Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Harvard Bioscience Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Harvard Bioscience Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Harvard Bioscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Harvard Bioscience Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Harvard Bioscience Inc (HBIO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
